Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 21951-22000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06885762
Efgartigimod for the Treatment of Guillain-Barré Syndrome
PHASE2/PHASE3Not yet recruiting
20 participants
Started: Apr 13, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT06893068
Clinical Intelligent Management System Pragmatic RCT
NARecruiting
204 participants
Started: Apr 13, 2025 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06931535
Remote Ischemic Conditioning for Acute Moderate Posterior Ischemic Stroke
NARecruiting
960 participants
Started: Apr 13, 2025 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT06760481
Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER)
PHASE1Active, not recruiting
7 participants
Started: Apr 13, 2025 · Completed: Sep 15, 2030
1 condition1 sponsor1 location
NCT06861283
Development and Validation of a Digital Twin-based Clinical Research System (X Town Stage I)
N/ARecruiting
1,500 participants
Started: Apr 13, 2025 · Completed: Aug 10, 2025
1 condition3 sponsors1 location
NCT06884410
Reproducibility of Multiparametric Renal Magnetic Resonance Imaging on 1.5T MRI Scanners
NARecruiting
48 participants
Started: Apr 12, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor4 locations
NCT06863571
Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Ischemic Stroke
PHASE3Recruiting
68 participants
Started: Apr 12, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT07004673
18F FDG and 68Ga FAPI PET/MR Imaging of Carotid Artery Plaque Vulnerability: A Clinical Study in Carotid Artery Plaque Patients
N/ARecruiting
100 participants
Started: Apr 12, 2025 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT06982391
Compassion, Social Support, Flexibility, and Resilience Program for Women Surviving Breast Cancer
NAEnrolling by invitation
20 participants
Started: Apr 12, 2025 · Completed: Apr 15, 2026
2 conditions1 sponsor1 location
NCT06692699
The A.R.R.E.S.T.® Spectacle Film Study
NARecruiting
160 participants
Started: Apr 12, 2025 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT06735742
A Study to Learn About the Safety of TALZENNA for the Treatment of Breast Cancer
N/AActive, not recruiting
3 participants
Started: Apr 12, 2025 · Completed: Mar 30, 2029
1 condition1 sponsor1 location
NCT07187193
Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH
PHASE2Recruiting
50 participants
Started: Apr 12, 2025 · Completed: Apr 13, 2027
1 condition1 sponsor1 location
NCT07187167
Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease
PHASE2Recruiting
40 participants
Started: Apr 12, 2025 · Completed: Apr 12, 2027
1 condition1 sponsor1 location
NCT06916624
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
N/ARecruiting
40 participants
Started: Apr 12, 2025 · Completed: Dec 31, 2026
2 conditions5 sponsors1 location
NCT06868550
Oral Health Promotion Vs. Standard Care in Egyptian Pregnant Women
NANot yet recruiting
58 participants
Started: Apr 12, 2025 · Completed: Mar 15, 2026
1 condition1 sponsor0 locations
NCT06913270
Virtual Reality Adjunct for Procedural Pain and Anxiety Management in Burn Wound Care
NARecruiting
100 participants
Started: Apr 12, 2025 · Completed: May 25, 2026
4 conditions1 sponsor1 location
NCT06980701
Improving Oral and Systemic Health in Individuals With Prediabetes Through Personalized Oral Hygiene Advice Provided by Dentists or by AI
NARecruiting
148 participants
Started: Apr 12, 2025 · Completed: Oct 25, 2025
2 conditions1 sponsor1 location
NCT06943001
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
NARecruiting
40 participants
Started: Apr 12, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT07005999
Interventional Ablation for Early-stage Lung Cancer
N/AActive, not recruiting
656 participants
Started: Apr 12, 2025 · Completed: Dec 31, 2028
2 conditions17 sponsors1 location
NCT06936540
The Effect of Virtual Tour Training Before Orthopedic Surgery
NARecruiting
70 participants
Started: Apr 12, 2025 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06942117
Investigating the Effect of Caffeine Consumption on Speech Understanding in Noise in Young Adults
NARecruiting
60 participants
Started: Apr 12, 2025 · Completed: Apr 13, 2026
1 condition1 sponsor1 location
NCT06875752
Is There a Need for Luteal Support in Modified Natural Cycle Frozen Embryo Transfer Cycles
PHASE4Recruiting
180 participants
Started: Apr 12, 2025 · Completed: Dec 1, 2026
2 conditions5 sponsors5 locations
NCT06962501
Acute Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity
NARecruiting
22 participants
Started: Apr 12, 2025 · Completed: Nov 1, 2025
2 conditions2 sponsors1 location
NCT07089186
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections
PHASE3Recruiting
80 participants
Started: Apr 12, 2025 · Completed: Apr 30, 2027
5 conditions1 sponsor1 location
NCT06897748
A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils
PHASE2Recruiting
98 participants
Started: Apr 12, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor13 locations
NCT06960343
Long Term Clinical Outcome After Arthroscopic Rotator Cuff Repair Augmentation With Autologous Microfragmented Lipoaspirate Tissue
N/ARecruiting
52 participants
Started: Apr 11, 2025 · Completed: Apr 11, 2026
3 conditions3 sponsors1 location
NCT06866938
Study of Re-treatment With [177Lu]Lu-PSMA in Men With Metastatic Castration Resistance Prostate Cancer
PHASE2Recruiting
58 participants
Started: Apr 11, 2025 · Completed: Apr 30, 2030
1 condition1 sponsor13 locations
NCT06935123
Impact of Nutritional Supplementation on Sleep Quality
PHASE1Not yet recruiting
376 participants
Started: Apr 11, 2025 · Completed: Oct 30, 2025
2 conditions1 sponsor1 location
NCT06429930
Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults
PHASE1Recruiting
56 participants
Started: Apr 11, 2025 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06926725
Effect of High Intensity Interval Training and Ultrasound Cavitation on Lipid Profile in Type 2 Diabetes Patients
NANot yet recruiting
66 participants
Started: Apr 11, 2025 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT06910696
Erector Spinae Plane Block Versus Modified Thoracolumbar Interfascial Plane Block
NAEnrolling by invitation
144 participants
Started: Apr 11, 2025 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06989801
Benefits of Outdoor Walks in Reducing Depressive Symptoms
NARecruiting
180 participants
Started: Apr 11, 2025 · Completed: Dec 27, 2025
1 condition1 sponsor2 locations
NCT06854016
Performance and Safety of LightForce® Therapy Lasers on Lateral Ankle Sprain
NARecruiting
108 participants
Started: Apr 11, 2025 · Completed: Sep 30, 2026
3 conditions1 sponsor8 locations
NCT06923735
Nutrition Apps in Occupational Healthcare (Pilot Study of the FOODNUTRI Project)
NAEnrolling by invitation
204 participants
Started: Apr 11, 2025 · Completed: Dec 31, 2025
9 conditions1 sponsor1 location
NCT07193069
Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning
N/ARecruiting
50 participants
Started: Apr 11, 2025 · Completed: Apr 11, 2026
6 conditions1 sponsor1 location
NCT06696001
Neuroscience of Psychotherapy for Depression
NARecruiting
45 participants
Started: Apr 11, 2025 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT06866574
A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males
PHASE3Active, not recruiting
9,300 participants
Started: Apr 11, 2025 · Completed: Sep 30, 2031
5 conditions2 sponsors4 locations
NCT06874374
Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder
NARecruiting
40 participants
Started: Apr 11, 2025 · Completed: Feb 28, 2026
2 conditions3 sponsors1 location
NCT06939543
The Test of Those Managing Pain With Their Own Pain
N/ANot yet recruiting
175 participants
Started: Apr 11, 2025 · Completed: Apr 30, 2025
1 condition1 sponsor0 locations
NCT06931938
Awake Prone Positioning in Spontaneous Breathing Patients With Acute Hypoxic Respiratory Failure Due to Pneumonia
NARecruiting
342 participants
Started: Apr 11, 2025 · Completed: Jun 30, 2027
1 condition4 sponsors1 location
NCT06968338
A Study to Assess the Safety of ARGX-213 in Healthy Volunteers
PHASE1Recruiting
72 participants
Started: Apr 11, 2025 · Completed: Jan 6, 2026
1 condition1 sponsor1 location
NCT06071429
Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
NARecruiting
300 participants
Started: Apr 11, 2025 · Completed: Mar 1, 2032
1 condition1 sponsor2 locations
NCT06968572
Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion
PHASE1Recruiting
245 participants
Started: Apr 11, 2025 · Completed: May 8, 2028
1 condition1 sponsor3 locations
NCT06916338
Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer
N/ARecruiting
30 participants
Started: Apr 11, 2025 · Completed: Dec 31, 2027
1 condition5 sponsors1 location
NCT06743620
Observational Registry for Iltamiocel Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
N/AEnrolling by invitation
96 participants
Started: Apr 11, 2025 · Completed: Apr 30, 2032
1 condition1 sponsor1 location
NCT06906458
Impact of Paresthesia on Postoperative Neurological Symptoms
N/ARecruiting
120 participants
Started: Apr 11, 2025 · Completed: Oct 15, 2025
2 conditions1 sponsor1 location
NCT06888830
A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour
PHASE1/PHASE2Recruiting
374 participants
Started: Apr 11, 2025 · Completed: Apr 1, 2027
1 condition1 sponsor1 location
NCT06877650
First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors
PHASE1Recruiting
270 participants
Started: Apr 11, 2025 · Completed: Mar 30, 2029
1 condition1 sponsor1 location
NCT06890884
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
PHASE2Recruiting
594 participants
Started: Apr 11, 2025 · Completed: Dec 16, 2032
1 condition1 sponsor55 locations
NCT06830746
ASCEND CSP IDE Study
NARecruiting
414 participants
Started: Apr 11, 2025 · Completed: May 31, 2028
2 conditions1 sponsor33 locations